AZ PHARMA
ActiveSummary
The computed 12-month bankruptcy probability of AZ PHARMA is 3.2% (moderate). The 2025 annual accounts show equity of €115,500 and a net result of €90,213. The figures fluctuate too strongly year-on-year for a reliable trend projection. The company has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals.
Group and network
Holdings and subsidiaries
2 holdingsHoldings 2
Source for every holding own accounts 2025
- PHARMACIE CHIFAsubsidiaryEquity €77,888Result €49,546100%
- PHARMACIE GALLAITsubsidiaryEquity €264,745Result €82,951100%
According to the 2025 annual accounts of AZ PHARMA and those of the other companies, the acts in the Belgian Official Gazette and the LEI register. Annual accounts state the shareholders that notified the company under article 7:225 of the Code of Companies and Associations and the parent companies that consolidate it. The register of ultimate beneficial owners (UBO) is not public: who ultimately stands behind a natural person or a foreign parent is not stated here. A company that does not include these statements in its annual accounts, or does not have to, is not listed.
Connections & network
No directors read yet: 0 of 1 Gazette act processed.